BioCryst Pharmaceuticals Inc logo

BioCryst Pharmaceuticals Inc

NEW
FRA:BO1 (USA)   Ordinary Shares
€ 9.05 -0.60 (-6.18%) Jul 10
At Loss
Market Cap:
€ 2.33B ($ 2.67B)
Enterprise V:
€ 2.84B ($ 3.25B)
Volume:
1.25K
Avg Vol (2M):
454.00
Trade In:

BioCryst Pharmaceuticals Inc Valuation Measures